Photobiomodulation (670 nm) for Aging Retina: Lifespan Signals from Flies to Mammals
Photobiomodulation at 670 nm targets mitochondria, the tiny structures inside cells that make most of our energy (ATP). In mitochondria, a key enzyme...
Deep research and expert guides on maintaining your visual health.
Photobiomodulation at 670 nm targets mitochondria, the tiny structures inside cells that make most of our energy (ATP). In mitochondria, a key enzyme...
Our visual field test is inspired by the perimetry methods eye care professionals use. Check for blind spots and track changes over time.
Test Your VisionA photoreceptor is a special cell in the eye that detects light and starts the process of vision by turning light into electrical signals the brain can understand. There are two main kinds in the retina: rods, which are very sensitive and help us see in low light, and cones, which detect color and fine detail and work best in brighter conditions. Each photoreceptor contains light-sensitive pigments that change shape when hit by photons, triggering a chemical cascade that creates an electrical signal. That signal is passed through other retinal cells and then along the optic nerve to the brain, where it becomes the images we see. Photoreceptors are arranged in a layered, organized pattern across the retina, with a high concentration of cones in the center for sharp vision and many rods around the edges for peripheral and night vision. Because they are finely tuned and active all the time, photoreceptors are vulnerable to damage from genetics, aging, disease, and sometimes excess light exposure. Problems with these cells underlie many vision disorders, such as certain inherited retinal diseases and forms of vision loss that come with aging. Protecting photoreceptors through healthy habits, early diagnosis, and treatments where available is key to preserving sight. Advances in research—including gene therapy, cell replacement, and electronic implants—aim to repair or replace damaged photoreceptors and restore vision for people affected by retinal diseases.